Algatechnologies Ltd.
Profile
Algatechnologies Ltd., established in 1998, is an innovative biotechnology company specializing in the development, production and commercialization of health related algae-based products for food/ beverage, dietary supplement and cosmeceutical market segments.
Competences & Capabilities
Algatechnologies first became known as a micro-algae leader with the production and worldwide sales of AstaPure®, a natural Astaxanthin from Haematococcus pluvialis, one of the most powerful antioxidants.
Located in Israel’s Arava Desert – with its stable climate and high light intensity – Algatechnologies is ideally positioned to cultivate microalgae.
Our commitment to sustainability is rooted deeply in our eco-friendly manufacturing and support processes. We utilize natural solar energy, recycle precious resources and clean wastewater.
Expertise related to the EIT Food Strategic Pillars
The state-of-the-art closed system, covering more than 15 acres of arid desert land, hosts a modular array of tubular glass photobioreactors, more than 500 km (310 miles) long. The entire system is automated and controlled remotely:
- A controlled closed microalgae cultivation system
- Green technology, energized by natural sunlight
- Supercritical CO2 extraction technology
- ISO, HACCP, non-GMO, kosher, halal and GMP certifications
Our core values
Algatechnologies takes a visionary approach to running a successful company, with a commitment to responsible practices across the business landscape. We aim for and achieve excellence in cultivation and science, leveraging green environmental approaches for a healthier planet, and provide safe, natural, high-quality products that align with our strategic priorities and values.
We implement our core values throughout our business, in our research & development, manufacturing, quality, marketing and sales.
Develop innovative algal plantbased protein sources with important functional properties needed for a wide variety of food and beverage applications. The project aims to develop cost-effect, highly functional and good tasting specialty proteins with important essential amino acid profiles; extracted to 70-80% total protein content (MFB); to be competitive with other alternative plant protein sources.
Algatech’s technology was developed nearly two decades ago in the lab for Microalgae Biotechnology at Ben-Gurion University (BGU), by Prof. Sammy Boussiba. In recent years, Algatech and the Microalgae Biotechnology Laboratory at BGU have collaborated in the European Commission FP7’s consortium of the GIAVAP project.
Algatech has received repeated grants from the Chief Scientist of Israel, for development of new microalgae sources with important health and nutrition benefits.